Castlerock Clinical Research Consultants

Tulsa, Oklahoma 74136

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Coronary Artery Disease, Hypertension, Myocardial Infarction, Unstable Angina

Studies at this site

• DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension — Completed
• DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension — Stopped early
• ARISE - Aggressive Reduction of Inflammation Stops Events — Status unconfirmed